Basic information
- Name:
L-Glutamic acid, sodiumsalt (1:1)
- Superlist Name:
- L-(+)Sodium glutamate
- CAS No.:
142-47-2
- Molecular Structure:

- Formula:
- C5H8NNaO4
- Molecular Weight:
- 169.13
- Deleted CAS:
- 116268-41-8|51959-41-2|56974-54-0
- Synonyms:
- Glutamicacid, monosodium salt, L- (8CI);L-Glutamic acid, monosodium salt (9CI);E 621;Glutacyl;Glutamic acid monosodium salt;L-Glutamic acid sodium salt;Monosodium L-glutamate;Sodium L-glutamate;Sodium hydrogen glutamate;Vetsin;Zest;
- EINECS:
- 205-538-1
- Melting Point:
- 232 °C
- Boiling Point:
- 333.8 °C at 760 mmHg
- Flash Point:
- 155.7 °C
- Solubility:
- water: >=10 g/100 mL at 20 °C
- Appearance:
- White or off-white crystalline powder with a slight peptone-like odor
- Risk Codes:
- 20/21/22
Famous Chemical Enterprises
-
Livzon -
Total -
Shell -
Dupont -
Exxonmobil -
Akzonobel -
Basf -
Bayer -
BP
Please post your buying leads,so that our qualified suppliers will soon
contact you!
*Required Fields
History
Although traditional Asian cuisine had often used seaweed extract, which contains high concentrations of glutamic acid, MSG was not isolated until 1907. MSG was subsequently patented by Ajinomoto Corporation of Japan in 1909.
Consensus Reports
Reported in EPA TSCA Inventory. EPA Genetic Toxicology Program.
Specification
The Monosodium Glutamate is an organic compound with the formula C5H8NNaO4. The IUPAC name of this chemical is sodium 2-amino-5-hydroxy-5-oxopentanoate. With the CAS registry number 142-47-2, it is also named as L-Glutamic acid monosodium salt. The product's classification codes are Food additives; Human Data; Mutation data; Reproductive Effect. Besides, it is a white or off-white crystalline powder with a slight peptone-like odor, which should be stored in a closed cool and dry place.
The Monosodium Glutamate is used as a food additive and is commonly marketed as a flavour enhancer. It is acceptable for celiacs following a gluten-free diet. But only the naturally occurring L-glutamate form is used as a flavour enhancer.
Physical properties about Monosodium Glutamate are: (1)ACD/LogP: -1.44; (2)ACD/LogD (pH 5.5): -4.7; (3)ACD/LogD (pH 7.4): -4.93; (4)ACD/BCF (pH 5.5): 1; (5)ACD/BCF (pH 7.4): 1; (6)ACD/KOC (pH 5.5): 1; (7)ACD/KOC (pH 7.4): 1; (8)#H bond acceptors: 5; (9)#H bond donors: 4; (10)#Freely Rotating Bonds: 5; (11)Polar Surface Area: 66.84 Å2; (12)Flash Point: 155.7 °C; (13)Enthalpy of Vaporization: 63.39 kJ/mol; (14)Boiling Point: 333.8 °C at 760 mmHg; (15)Vapour Pressure: 2.55E-05 mmHg at 25°C.
Preparation: this chemical can be prepared by rice, starch or molasses. Chemical reaction equation is as follows:
(C6H10O5)N[H2O]→C6H12O6[NH3,O2] →C5H9NO4[Na2CO3] →C5H8NNaO4
You can still convert the following datas into molecular structure:
(1)SMILES: [Na+].O=C([O-])[C@@H](N)CCC(=O)O
(2)InChI: InChI=1/C5H9NO4.Na/c6-3(5(9)10)1-2-4(7)8;/h3H,1-2,6H2,(H,7,8)(H,9,10);/q;+1/p-1/t3-;/m0./s1
(3)InChIKey: LPUQAYUQRXPFSQ-SYBSRVMOBZ
(4)Std. InChI: InChI=1S/C5H9NO4.Na/c6-3(5(9)10)1-2-4(7)8;/h3H,1-2,6H2,(H,7,8)(H,9,10);/q;+1/p-1/t3-;/m0./s1
(5)Std. InChIKey: LPUQAYUQRXPFSQ-DFWYDOINSA-M
The toxicity data is as follows:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| cat | LD50 | subcutaneous | 8gm/kg (8000mg/kg) | Personal Communication from A.G. Ebert, International Glutamate Technical Committee, 85 Walnu St., Watertown, MA 02172, Nov. 19, 1973Vol. 19NOV1973, | |
| guinea pig | LD50 | intraperitoneal | 15gm/kg (15000mg/kg) | FAO Nutrition Meetings Report Series. Vol. 53A, Pg. 424, 1974. | |
| human | TDLo | intravenous | 714ug/kg (0.714mg/kg) | BEHAVIORAL: HEADACHE | Science. Vol. 163, Pg. 826, 1969. |
| human | TDLo | oral | 43mg/kg (43mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" GASTROINTESTINAL: NAUSEA OR VOMITING | Hygiene and Sanitation Vol. 36(9), Pg. 364, 1971. |
| man | TDLo | oral | 3571ug/kg (3.571mg/kg) | SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | Lancet. Vol. 1, Pg. 988, 1987. |
| mouse | LD50 | intraperitoneal | 3800mg/kg (3800mg/kg) | Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 227, Pg. 214, 1955. | |
| mouse | LD50 | intravenous | 30gm/kg (30000mg/kg) | FAO Nutrition Meetings Report Series. Vol. 53A, Pg. 424, 1974. | |
| mouse | LD50 | oral | 11400mg/kg (11400mg/kg) | Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 227, Pg. 214, 1955. | |
| mouse | LD50 | subcutaneous | 8200mg/kg (8200mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: EXCITEMENT | Oyo Yakuri. Pharmacometrics. Vol. 15, Pg. 433, 1978. |
| rat | LD50 | intraperitoneal | 4253mg/kg (4253mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: TETANY | Hoppe-Seyler's Zeitschrift fuer Physiologische Chemie. Vol. 300, Pg. 97, 1955. |
| rat | LD50 | intravenous | 3300mg/kg (3300mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE BEHAVIORAL: ATAXIA AUTONOMIC NERVOUS SYSTEM: OTHER (DIRECT) PARASYMPATHOMIMETIC | Oyo Yakuri. Pharmacometrics. Vol. 15, Pg. 433, 1978. |
| rat | LD50 | oral | 16600mg/kg (16600mg/kg) | Farmaco, Edizione Pratica. Vol. 27, Pg. 19, 1972. | |
| rat | LD50 | subcutaneous | 5580mg/kg (5580mg/kg) | BEHAVIORAL: TREMOR LUNGS, THORAX, OR RESPIRATION: CYANOSIS BEHAVIORAL: ATAXIA | Oyo Yakuri. Pharmacometrics. Vol. 15, Pg. 433, 1978. |
| women | TDLo | oral | 50mg/kg (50mg/kg) | LUNGS, THORAX, OR RESPIRATION: DYSPNEA | New England Journal of Medicine. Vol. 305, Pg. 1154, 1981. |

